Publication: Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: A multicenter trial of the Forum for Nuclear Cooperation in Asia
Issued Date
2013-05-01
Resource Type
ISSN
13499157
04493060
04493060
Other identifier(s)
2-s2.0-84877760735
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Radiation Research. Vol.54, No.3 (2013), 467-473
Suggested Citation
Tatsuya Ohno, Dang Huy Quoc Thinh, Shingo Kato, C. R Beena Devi, Ngo Thanh Tung, Kullathorn Thephamongkhol, Miriam Joy C Calaguas, Juying Zhou, Yaowalak Chansilpa, Nana Supriana, Dyah Erawati, Parvin Akhter Banu, Cho Chul Koo, Kunihiko Kobayashi, Takashi Nakano, Hirohiko Tsujii Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: A multicenter trial of the Forum for Nuclear Cooperation in Asia. Journal of Radiation Research. Vol.54, No.3 (2013), 467-473. doi:10.1093/jrr/rrs115 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/31797
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: A multicenter trial of the Forum for Nuclear Cooperation in Asia
Other Contributor(s)
Gunma University
Ho Chi Minh City Oncology Hospital
Saitama Medical University
Sarawak General Hospital
National Cancer Hospital
Mahidol University
St. Luke's Medical Center Quezon City
Soochow University
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
Dr. Soetomo Hospital
Delta Hospitals Limited
Korea Cancer Center Hospital
Gunma University Faculty of Medicine
National Institute of Radiological Sciences Chiba
Ho Chi Minh City Oncology Hospital
Saitama Medical University
Sarawak General Hospital
National Cancer Hospital
Mahidol University
St. Luke's Medical Center Quezon City
Soochow University
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
Dr. Soetomo Hospital
Delta Hospitals Limited
Korea Cancer Center Hospital
Gunma University Faculty of Medicine
National Institute of Radiological Sciences Chiba
Abstract
The purpose of this study was to evaluate the efficacy and toxicity of radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for the treatment of N2-3 nasopharyngeal cancer (NPC) in Asian countries, especially regions of South and Southeast Asian countries where NPC is endemic. Between 2005 and 2009, 121 patients with NPC (T1-4 N2-3 M0) were registered from Vietnam, Malaysia, Indonesia, Thailand, The Philippines, China and Bangladesh. Patients were treated with 2D radiotherapy concurrently with weekly cisplatin (30 mg/m 2), followed by adjuvant chemotherapy, consisting of cisplatin (80 mg/m2 on Day 1) and fluorouracil (800 mg/m2 on Days 1-5) for 3 cycles. Of the 121 patients, 56 patients (46%) required interruption of RT. The reasons for interruption of RT were acute non-hematological toxicities such as mucositis, pain and dermatitis in 35 patients, hematological toxicities in 11 patients, machine break-down in 3 patients, poor general condition in 2 patients, and others in 8 patients. Of the patients, 93% completed at least 4 cycles of weekly cisplatin during radiotherapy, and 82% completed at least 2 cycles of adjuvant chemotherapy. With a median follow-up time of 46 months for the surviving 77 patients, the 3-year locoregional control, distant metastasis-free survival and overall survival rates were 89%, 74% and 66%, respectively. No treatment-related deaths occurred. Grade 3-4 toxicities of mucositis, nausea/vomiting and leukopenia were observed in 34%, 4% and 4% of the patients, respectively. In conclusion, further improvement in survival and locoregional control is necessary, although our regimen showed acceptable toxicities. © 2012 The Author 2012.